Omeros | OMER - Frais De Vente Et D'Administration





Frais De Vente Et D'Administration Changement Date
Adma Biologics USD 20.19M 2.86M 2025-12
Alnylam Pharmaceuticals USD 285.06M 22.47M 2025-12
BioMarin Pharmaceutical USD 322.21M 98.79M 2025-12
Cytokinetics USD 91.72M 67.02M 2025-12
Gilead Sciences USD 1.78B 425M 2025-12
Heron Therapeutics USD 23.74M 605K 2025-12
Immunic USD -0.24 0.03 2024-09
Insmed USD 212.48M 26.11M 2025-12
Knight Therapeutics CAD 35.45M 4.43M 2025-12
MacroGenics USD 7.94M 1.96M 2025-12
Omeros USD 11.32M 2.48M 2024-09
Pacira USD 91.87M 70K 2025-12
Pfizer USD 4.08B 894M 2025-12
Rockwell Medical USD 4.04M 330K 2024-06
Sangamo BioSciences USD 9.64M 1.83M 2024-06
Sarepta Therapeutics USD 105.38M 28.27M 2025-12
United Therapeutics USD 190.6M 38.6M 2025-12
Vertex Pharmaceuticals USD 487M 41.9M 2025-12
Xoma USD 11M 2.54M 2024-06